- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-10-0001483

Mediforce Research Private Limited
About Mediforce Research Private Limited
Data last updated:
Mediforce Research Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mediforce Healthcare Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 01 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC461315. Its GSTIN is 02AANCM0447R1Z3 (Himachal Pradesh).
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹8 Cr. It is led by directors including Brijeshwar Dutt Tyagi and Nikunj Tyagi.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.92 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹1.19 Cr (net margin -17.2%) and EBITDA of ₹25.6 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
The company has about 66 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr on record.
Mediforce Research Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0001483). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Mediforce Research has one previous CIN (Corporate Identification Number): U24290HP2019PTC007675. The current CIN is U24290DL2019PTC461315, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24290DL2019PTC461315 | Current |
| U24290HP2019PTC007675 | Previous |
Recognitions & Rankings of Mediforce Research
Contact details
Mediforce Research Private Limited's registered office is in New Delhi, Delhi.
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Mediforce Research are professional, scientific and technical and manufacturing. In detail, this covers scientific research and development and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mediforce Research Private Limited, buy the company report.
Financials of Mediforce Research Private Limited
FY 2025 filings availableMediforce Research Private Limited reported revenue of ₹6.92 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 5% growth in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | -17.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mediforce Research Private Limited, buy the company report.
Board of directors of Mediforce Research Private Limited
Mediforce Research has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijeshwar Dutt Tyagi | Director | 01 Nov 2019 | 7 Years 0 Months | Current |
| Nikunj Tyagi Also directs: Shriom Organics Private Limited, Yvns Momkidsfashion LLP, Sirmour Remedies Private Limited and 4 more | Director | 01 Nov 2019 | 7 Years 0 Months | Current |
| Arjun Singh Also directs: Qualitek Starch Private Limited, Sirmour Remedies Private Limited, Pharmaforce Medex Private Limited and 1 more | Director | 17 Mar 2021 | 5 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2024 | 100973349 | Hdfc Bank Limited | ₹3 Cr | Open |
To see the full charge records of Mediforce Research Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mediforce Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediforce Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mediforce Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AANCM0447R1Z3 | Himachal Pradesh | Active | 09 Jan 2020 |
To see the full GST registrations and return filing status of Mediforce Research Private Limited, buy the company report.
Recent activity
Mediforce Research Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Arjun Singh ceased to be Additional Director on 29 Nov 2021.
Frequently asked questions
Mediforce Research is an active private limited company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 01 November 2019 (7+ years old) and is registered under CIN U24290DL2019PTC461315.
Mediforce Research has 3 current directors:
- Brijeshwar Dutt Tyagi - Director
- Nikunj Tyagi - Director
- Arjun Singh - Director
The latest financial statements of Mediforce Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mediforce Research is 02AANCM0447R1Z3, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Mediforce Research is U24290DL2019PTC461315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediforce Research was incorporated on 01 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Arjun Singh ceased to be Additional Director on 29 Nov 2021. Arjun Singh was appointed as Director on 17 Mar 2021. Brijeshwar Dutt Tyagi was appointed as Director on 01 Nov 2019. Mediforce Research has 4 board changes on record in total.
Yes, Mediforce Research is registered as a small enterprise under Udyam registration (number: UDYAM-HP-10-0001483).
The registered office of Mediforce Research is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
Mediforce Research operates in the pharma industry, in the pharma contract r and d segment.

